Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders
Sophie Erhardt, Ana Pocivavsek, Mariaelena Repici, et al.
Biological Psychiatry (2016) Vol. 82, Iss. 10, pp. 756-765
Open Access | Times Cited: 57

Showing 26-50 of 57 citing articles:

Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies
Jacopo Sapienza, Marco Spangaro, Gilles J. Guillemin, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 6, pp. 1317-1328
Closed Access | Times Cited: 17
Role of Kynurenine and Its Derivatives in Liver Diseases: Recent Advances and Future Clinical Perspectives
Qi-Wen Tan, Shenghe Deng, Lijuan Xiong
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 968-968
Open Access
UPF 648, a Selective KMO Inhibitor, Attenuates Psychomotor and Cognitive Impairment in Chronic Kidney Disease
Aparajita Ghosh, Neeraja Rayanki, A. Joshi, et al.
ACS Chemical Neuroscience (2025) Vol. 16, Iss. 5, pp. 908-919
Closed Access
Kynurenine amplifies tetrahydrocannabinol-induced sensorimotor impairment and classic “tetrad” effects in mice
Sabrine Bilel, Giorgia Corli, Edoardo Tiziani, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111342-111342
Closed Access
Parental kynurenine 3-monooxygenase genotype in mice directs sex-specific behavioral outcomes in offspring
Snezana Milosavljevic, Maria V. Piroli, Emma J Sandago, et al.
Biology of Sex Differences (2025) Vol. 16, Iss. 1
Open Access
Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients
Gregory F. Oxenkrug, Marieke van der Hart, Julien Roeser, et al.
Integrative Clinical Medicine (2017) Vol. 1, Iss. 1
Open Access | Times Cited: 32
Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia
Maximilian Tufvesson‐Alm, Lilly Schwieler, Robert Schwarcz, et al.
Neuropharmacology (2018) Vol. 138, pp. 130-139
Open Access | Times Cited: 32
Linking phencyclidine intoxication to the tryptophan-kynurenine pathway: Therapeutic implications for schizophrenia
Hidetsugu Fujigaki, Akihiro Mouri, Yasuko Yamamoto, et al.
Neurochemistry International (2019) Vol. 125, pp. 1-6
Closed Access | Times Cited: 26
The Effects of Maternal Interleukin-17A on Social Behavior, Cognitive Function, and Depression-Like Behavior in Mice with Altered Kynurenine Metabolites
Yuki Murakami, Yukio Imamura, Yoshiyuki Kasahara, et al.
International Journal of Tryptophan Research (2021) Vol. 14
Open Access | Times Cited: 22
Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice
Francesca M. Notarangelo, Sarah Beggiato, Robert Schwarcz
Developmental Neuroscience (2019) Vol. 41, Iss. 1-2, pp. 102-111
Open Access | Times Cited: 23
Effects of IDO1 and TDO2 inhibition on cognitive deficits and anxiety following LPS-induced neuroinflammation
Sophie Imbeault, Michel Goiny, Xicong Liu, et al.
Acta Neuropsychiatrica (2019) Vol. 32, Iss. 1, pp. 43-53
Closed Access | Times Cited: 23
Kynurenine‐3‐monooxygenase: A new direction for the treatment in different diseases
Yifei Lü, Mingmei Shao, Tao Wu
Food Science & Nutrition (2020) Vol. 8, Iss. 2, pp. 711-719
Open Access | Times Cited: 21
GRK3 deficiency elicits brain immune activation and psychosis
Carl M. Sellgren, Sophie Imbeault, Markus K. Larsson, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 11, pp. 6820-6832
Open Access | Times Cited: 17
Reducing brain kynurenic acid synthesis precludes kynurenine‐induced sleep disturbances
Katherine M. Rentschler, Snezana Milosavljevic, Annalisa M. Baratta, et al.
Journal of Sleep Research (2023) Vol. 33, Iss. 3
Open Access | Times Cited: 7
Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis
Henrique Lemos, Eslam Mohamed, Rong Ou, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 17
Kynurenine pathway dysregulation as a mechanistic link between cognitive impairment and brain damage: Implications for multiple sclerosis
Marie Kupjetz, Tiffany Y. Wences Chirino, Niklas Joisten, et al.
Brain Research (2024), pp. 149415-149415
Open Access | Times Cited: 2
Alterations in rat prefrontal cortex kynurenic acid levels are involved in the enduring cognitive dysfunctions induced by tetrahydrocannabinol exposure during the adolescence
Sarah Beggiato, Alessandro Ieraci, Mariachiara Zuccarini, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 10
Dual administration of lipopolysaccharide induces behavioural changes in rats relevant to psychotic disorders
Yiran Zheng, Maximilian Tufvesson‐Alm, Ada Trepci, et al.
Acta Neuropsychiatrica (2023), pp. 1-13
Open Access | Times Cited: 5
LPS-induced cortical kynurenic acid and neurogranin-NFAT signaling is associated with deficits in stimulus processing during Pavlovian conditioning
Alfredo Oliveros, Katheryn Wininger, Jonathon Sens, et al.
Journal of Neuroimmunology (2017) Vol. 313, pp. 1-9
Open Access | Times Cited: 16
Repeated administration of LPS exaggerates amphetamine-induced locomotor response and causes learning deficits in mice
Maximilian Tufvesson‐Alm, Sophie Imbeault, Xi-Cong Liu, et al.
Journal of Neuroimmunology (2020) Vol. 349, pp. 577401-577401
Closed Access | Times Cited: 14
Influx of kynurenine into the brain is involved in the reduction of ethanol consumption induced by Ro 61‐8048 after chronic intermittent ethanol in mice
Leticia Gil de Biedma‐Elduayen, Pablo Giménez‐Gómez, Nuria Morales‐Puerto, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 14, pp. 3711-3726
Open Access | Times Cited: 9
Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia
Sarah Beggiato, Francesca M. Notarangelo, Korrapati V. Sathyasaikumar, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 11, pp. 1223-1232
Open Access | Times Cited: 12
Kynurenine 3-Monooxygenase Gene Associated With Nicotine Initiation and Addiction: Analysis of Novel Regulatory Features at 5′ and 3′-Regions
Hassan A. Aziz, Abdel‐Salam G. Abdel‐Salam, Mohammed A. I. Al-Obaide, et al.
Frontiers in Genetics (2018) Vol. 9
Open Access | Times Cited: 9
Assessing and Modulating Kynurenine Pathway Dynamics in Huntington’s Disease: Focus on Kynurenine 3-Monooxygenase
Korrapati V. Sathyasaikumar, Carlo Breda, Robert Schwarcz, et al.
Methods in molecular biology (2018), pp. 397-413
Closed Access | Times Cited: 9
Developmental Exposure to Kynurenine Affects Zebrafish and Rat Behavior
Marta Marszałek‐Grabska, Kinga Gaweł, Nataliia Kosheva, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2224-2224
Open Access | Times Cited: 3

Scroll to top